Kaleido Biosciences

Developer of microbiome metabolic therapies for inflammatory conditions

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups81 employees language kaleido.com

Registered entities

Innovation

19 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 2,118 times.

YearFilings
20164
20175
20187
20198
202013
202112
20229
20235
20241
20252

Investor mix

9 investors on record; lead investors include Flagship Pioneering, Array, Invus, Rock Springs Capital.

Investor typeCountShare
Venture capital556%
Private equity111%
Other / undisclosed333%
Coming soon